Skip to main content

Table 2 Spearman correlation analyses between PCSK9 and metabolism and inflammation makers according to diabetes status

From: Association of PCSK9 with inflammation and platelet activation markers and recurrent cardiovascular risks in STEMI patients undergoing primary PCI with or without diabetes

 

Whole cohort (n = 1027)

DM (n = 277)

Non-DM (n = 750)

 

r

P

r

P

r

P

Metabolism related markers

      

 Body mass index

0.021

0.507

− 0.020

0.747

0.034

0.355

 Fasting glucose

− 0.038

0.229

− 0.133

0.031

− 0.018

0.622

 HbA1C

0.040

0.207

− 0.048

0.438

0.062

0.096

 Total cholesterol

0.044

0.164

0.038

0.536

0.047

0.210

 LDL-C

0.005

0.872

− 0.039

0.525

0.022

0.549

 HDL-C

− 0.081

0.011

0.023

0.706

− 0.120

0.001

 Triglycerides

0.146

< 0.001

0.214

< 0.001

0.111

0.003

 Lipoprotein(a)

0.075

0.019

0.048

0.438

0.089

0.017

Inflammatory marker

      

 hs-CRP

0.112

< 0.001

0.205

0.001

0.076

0.041

  1. PCSK9 proprotein convertase subtilisin/kexin type 9, DM diabetes mellitus, non-DM non-diabetes mellitus, HbA1C hemoglobin A1c, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, hs-CRP high-sensitivity C reactive protein, sCD40L soluble CD40 ligand
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840